| 2D Structure | |
| CID | 3476 |
| IUPAC Name | 4-ethyl-3-methyl-N-[2-[4-[(4-methylcyclohexyl)carbamoylsulfamoyl]phenyl]ethyl]-5-oxo-2H-pyrrole-1-carboxamide |
| InChI | InChI=1S/C24H34N4O5S/c1-4-21-17(3)15-28(22(21)29)24(31)25-14-13-18-7-11-20(12-8-18)34(32,33)27-23(30)26-19-9-5-16(2)6-10-19/h7-8,11-12,16,19H,4-6,9-10,13-15H2,1-3H3,(H,25,31)(H2,26,27,30) |
| InChI Key | WIGIZIANZCJQQY-UHFFFAOYSA-N |
| Canonical SMILES | None |
| Isomeric SMILES | None |
| Molecular Formula | C24H34N4O5S |
| Molecular Weight | 490.6 |
| synonyms | ['1H-Pyrrole-1-carboxamide, 3-ethyl-2,5-dihydro-4-methyl-N-2-4-(trans-4-methylcyclohexyl)aminocarbonylaminosulfonylphenylethyl-2-oxo-', '1H-Pyrrole-1-carboxamide, 3-ethyl-2,5-dihydro-4-methyl-N-[2-[4-[[[[(trans-4-methylcyclohexyl)amino]carbonyl]amino]sulfonyl]phenyl]ethyl]-2-oxo-', '1H-Pyrrole-1-carboxamide, 3-ethyl-2,5-dihydro-4-methyl-N-(2-(4-(((((trans-4-methylcyclohexyl)amino)carbonyl)amino)sulfonyl)phenyl)ethyl)-2-oxo-', 'RefChem:439179', 'glimepiride', '93479-97-1', 'Amaryl', 'cis-Glimepiride', '684286-46-2', 'Glimepirida', 'Glimepirid', 'Glimepiridum', 'Amarel', 'Endial', 'Hoe-490', 'Glimepride', 'HOE 490', 'Glimepiride Impurity A', 'Glimepiride, cis-', '4-ethyl-3-methyl-N-[2-[4-[(4-methylcyclohexyl)carbamoylsulfamoyl]phenyl]ethyl]-5-oxo-2H-pyrrole-1-carboxamide', '261361-60-8', 'C24H34N4O5S', '1-((p-(2-(3-Ethyl-4-methyl-2-oxo-3-pyrroline-1-carboxamido)ethyl)phenyl)sulfonyl)-3-(trans-4-methylcyclohexyl)urea', 'NSC-759809', '24T6XIR2MZ', 'CHEBI:5383', 'DTXSID5040675', 'Glimepiride for system suitability', 'MFCD00878417', '6KY687524K', '3-Ethyl-4-methyl-N-(4-(N-((cis-4-methylcyclohexyl)carbamoyl)sulfamoyl)phenethyl)-2-oxo-2,5-dihydro-1H-pyrrole-1-carboxamide', '3-ethyl-4-methyl-N-{2-[4-({[(4-methylcyclohexyl)carbamoyl]amino}sulfonyl)phenyl]ethyl}-2-oxo-2,5-dihydro-1H-pyrrole-1-carboxamide', 'NCGC00016960-03', 'Glimepiridum [Latin]', 'Glimepirida [Spanish]', 'CAS-93479-97-1', 'Glista OD', '1H-Pyrrole-1-carboxamide, 3-ethyl-2,5-dihydro-4-methyl-N-(2-(4-(((((4-methylcyclohexyl)amino)carbonyl)amino)sulfonyl)phenyl)ethyl)-2-oxo-, trans-', '3-ethyl-4-methyl-2-oxo-N-(2-{4-[({[(1r,4r)-4-methylcyclohexyl]carbamoyl}amino)sulfonyl]phenyl}ethyl)-2,5-dihydro-1H-pyrrole-1-carboxamide', 'Ristomycin Monosulfate (90%)', 'DTXCID3020675', 'Glymepirid', 'Glorion', 'Glemax', 'Glimer', 'Roname', 'Solosa', 'Glimepiride EP Impurity A', 'Ristocetin Sulfate; Ristomycin Sulfate', '1-[[4-[2-[[(3-Ethyl-4-methyl-2-oxo-2,3-dihydro-1H-pyrrol-1-yl)carbonyl]amino]ethyl]phenyl]sulphonyl]-3-(cis-4-methylcyclohexyl)urea (cis-Glimepiride)', '1-[[P-[2-(3-ETHYL-4-METHYL-2-OXO-3-PYRROLINE-1-CARBOXAMIDO)ETHYL]PHENYL]SULFONYL]-3-(TRANS-4-METHYLCYCLOHEXYL)UREA', '3-ethyl-4-methyl-N-(4-(N-(((1r,4r)-4-methylcyclohexyl)carbamoyl)sulfamoyl)phenethyl)-2-oxo-2,5-dihydro-1H-pyrrole-1-carboxamide', '3-Ethyl-4-methyl-N-(4-(N-((rel-(1r,4r)-4-methylcyclohexyl)carbamoyl)sulfamoyl)phenethyl)-2-oxo-2,5-dihydro-1H-pyrrole-1-carboxamide', '3-ethyl-4-methyl-N-[2-(4-{[(4-methylcyclohexyl)carbamoyl]sulfamoyl}phenyl)ethyl]-2-oxo-2,5-dihydro-1H-pyrrole-1-carboxamide', 'SMR000466368', 'SL-NH2 Trifluoroacetic Acid Salt (1:2)', 'Amaryl (TN)', 'CCRIS 7083', 'SR-05000001508', 'UNII-24T6XIR2MZ', 'BRN 5365754', 'gimepiride', 'Niddaryl', 'Sugral', 'Glimepiridum;', 'Glimepirid;', 'Glimepirida;', 'Glimepride;', 'HOE490', 'Glimepiride CRS', 'Amarel;', 'Amaryl;', 'UNII-6KY687524K', 'Glimepiride [USAN:USP:INN:BAN]', 'Glimepiride; 3-Ethyl-2,5-dihydro-4-methyl-N-[2-[4-[[[[(trans-4-methylcyclohexyl)amino]carbonyl]amino]sulfonyl]phenyl]ethyl] 2-oxo-1H-pyrrole-1-carboxamide; Amaryl; Glimperide; HOE 490; trans-3-Ethyl-2,5-dihydro-4-methyl-N-[2-[4-[[[[(4-methylcyclohexyl)amino]carbonyl]amino]sulfonyl]phenyl]ethyl] 2-oxo-1H-pyrrole-1-carboxamide', 'Amaryl, Glista OD', 'Glimepiride (Standard)', 'CPD000466368', 'GLIMEPIRIDE [MI]', 'Prestwick0_000651', 'Prestwick1_000651', 'Prestwick2_000651', 'Prestwick3_000651', 'GLIMEPIRIDE [INN]', 'GLIMEPIRIDE [JAN]', 'GLIMEPIRIDE [USAN]', 'GLIMEPIRIDE [VANDF]', 'CHEMBL1481', 'GLIMEPIRIDE [MART.]', 'Oprea1_382896', 'SCHEMBL16084', 'SCHEMBL16086', 'BSPBio_000681', 'GLIMEPIRIDE [USP-RS]', 'GLIMEPIRIDE [WHO-DD]', 'GLIMEPIRIDE CIS-ISOMER', 'MLS000759495', 'MLS001076674', 'MLS001401419', 'MLS003915622', 'MLS006011260', 'SPBio_002602', 'GLIMEPIRIDE [EMA EPAR]', 'BPBio1_000751', 'CHEMBL149223', 'GTPL6820', 'orb1310911', 'Glimepiride (JP18/USP/INN)', 'Glimepiride - Bio-X trade mark', 'SCHEMBL14965363', 'CHEBI:92609', 'HY-B0104R', 'DTXSID20861130', 'GLIMEPIRIDE [ORANGE BOOK]', 'MSK7192', 'GLIMEPIRIDE [EP MONOGRAPH]', 'GLIMEPIRIDE [USP IMPURITY]', 'GLXC-06551', 'HMS1570C03', 'HMS2052L03', 'HMS2090K18', 'HMS2097C03', 'HMS2235L07', 'HMS3269A09', 'HMS3372O07', 'HMS3394L03', 'HMS3413K06', 'HMS3654F17', 'HMS3677K06', 'HMS3714C03', 'HMS5079H13', 'Pharmakon1600-01504915', 'GLIMEPIRIDE [USP MONOGRAPH]', 'MSK7192-100AM', 'DRB80990', 'DUETACT COMPONENT GLIMEPIRIDE', 'HY-B0104', 'MSK7192-1000AM', 'Tox21_110713', 'AC-476', 'BDBM50237590', 'EBC-07868', 'EBC-08673', 'NSC759809', 'NSC813217', 's1344', 'STL451059', 'STL453194', 'AKOS015894919', 'AKOS015969663', 'Glimepiride for system suitability CRS', 'Glimepiride, >=98% (HPLC), solid', 'Tox21_110713_1', 'AB07644', 'CCG-101156', 'CS-1844', 'DB00222', 'FG23667', 'FG23668', 'KS-5238', 'NC00406', 'NSC 759809', 'NSC-813217', 'NCGC00016960-01', 'NCGC00016960-02', 'NCGC00016960-04', 'NCGC00016960-05', 'NCGC00016960-07', 'NCGC00161404-01', 'NCGC00161404-02', 'NCGC00181757-01', 'NCGC00371061-02', 'NCGC00371061-06', '1-{[4-(2-{[(3-ethyl-4-methyl-2-oxo-2,5-dihydro-1H-pyrrol-1-yl)carbonyl]amino}ethyl)phenyl]sulfonyl}-3-(trans-4-methylcyclohexyl)urea', '1H-Pyrrole-1-carboxamide, 2,5-dihydro-3-ethyl-4-methyl-N-(2-(4-(((((4-methylcyclohexyl)amino)carbonyl)amino)sulfonyl)phenyl)ethyl)-2-oxo-, trans-', '3-ethyl-4-methyl-n-(4-(n-((1r,4r)-4-methylcyclohexylcarbamoyl)sulfamoyl)phenethyl)-2-oxo-2,5-dihydro', '3-ethyl-4-methyl-N-[2-(4-{[(trans-4-methylcyclohexyl)carbamoyl]sulfamoyl}phenyl)ethyl]-2-oxo-2,5-dihydro-1H-pyrrole-1-carboxamide', 'BG164507', 'SMR001550123', 'Glimepiride 100 microg/mL in Acetonitrile', 'AB00513874', 'CS-0165191', 'G0395', 'GLIMEPIRIDE IMPURITY A [EP IMPURITY]', 'NS00004860', 'SW196369-4', 'C07669', 'D00593', 'H36404', 'AB00513874-06', 'AB00513874-08', 'AB00513874-09', 'AB00513874_10', 'AB00513874_11', 'EN300-19873446', 'Q425027', 'SR-05000001508-1', 'SR-05000001508-2', 'SR-05000001508-3', 'BRD-K34776109-001-03-4', 'BRD-K34776109-001-14-1', 'BRD-K34776109-001-15-8', 'BRD-K34776109-001-16-6', 'BRD-K42693031-001-01-8', 'Q27253874', 'Glimepiride Solution in Acetonitrile/Methanol, 100ug/mL', 'Z1501475009', 'Glimepiride Solution in Acetonitrile/Methanol, 1000ug/mL', 'Glimepiride, British Pharmacopoeia (BP) Reference Standard', 'Glimepiride, European Pharmacopoeia (EP) Reference Standard', 'Glimepiride, United States Pharmacopeia (USP) Reference Standard', 'Glimepiride for system suitability, European Pharmacopoeia (EP) Reference Standard', '1-((4-(2-(((3-ETHYL-4-METHYL-2-OXO-2,3-DIHYDRO-1H-PYRROL-1-YL)CARBONYL)AMINO)ETHYL)PHENYL)SULFONYL)-3-(CIS-4-METHYLCYCLOHEXYL)UREA', '1-[[p-[2-(3-Ethyl-4-methyl-2-oxo-3-pyrroline-1-carboxamido)ethyl]phenyl]sulfonyl]-3-(trans-4-methylcycloh', '1-[4-[2-(3-Ethyl-4-methyl-2-oxo-3-pyrroline-1-carboxamido) ethyl] phenylsulfonyl]-3-(4-cis-methylcyclohexyl)urea', '1H-PYRROLE-1-CARBOXAMIDE, 3-ETHYL-2,5-DIHYDRO-4-METHYL-N-(2-(4-(((((CIS-4-METHYLCYCLOHEXYL)AMINO)CARBONYL)AMINO)SULFONYL)PHENYL)ETHYL)-2-OXO-', '1H-Pyrrole-1-carboxamide, 3-ethyl-2,5-dihydro-4-methyl-N-[2-[4-[[[[(trans- 4-methylcyclohexyl)amino]carbonyl]amino]sulfonyl]phenyl]ethyl]-2-oxo-', '3-Ethyl-2,5-dihydro-4-methyl-N-[2-[4-[[[[(4-methylcyclohexyl)amino]carbonyl]amino]sulfonyl]phenyl]ethyl]-2-oxo-1H-pyrrole-1-carboxamide', '3-ethyl-4-methyl-N-(4-(N-(((1s,4s)-4-methylcyclohexyl)carbamoyl)sulfamoyl)phenethyl)-2-oxo-2,5-dihydro-1H-pyrrole-1-carboxamide? (Glimepiride Impurity pound(c)', '3-Ethyl-4-methyl-N-(4-[N-((1r,4r)-4-methylcyclohexylcarbamoyl)sulfamoyl]phenethyl)-2-oxo-2,5-dihydro-1H-pyrrole-1-carboxamide', '3-ethyl-4-methyl-N-[2-(4-{[(cis-4-methylcyclohexyl)carbamoyl]sulfamoyl}phenyl)ethyl]-2-oxo-2,5-dihydro-1H-pyrrole-1-car', '3-ethyl-4-methyl-N-[2-(4-{[(cis-4-methylcyclohexyl)carbamoyl]sulfamoyl}phenyl)ethyl]-2-oxo-2,5-dihydro-1H-pyrrole-1-car boxamide', '3-Ethyl-4-Methyl-N-[2-(4-{[(Cis-4-Methylcyclohexyl)carbamoyl]sulfamoyl}phenyl)ethyl]-2-Oxo-2,5-Dihydro-1h-Pyrrole-1-Carboxamide', '3-Ethyl-4-methyl-N-{2-[4-({[(1r,4r)-4-methylcyclohexyl]carbamoyl}sulfamoyl)phenyl]ethyl}-2-oxo-2,5-dihydro-1H-pyrrole-1-carboxamide', 'cis-3-Ethyl-2,5-dihydro-4-methyl-N-[2-[4-[[[[(cis-4-methylcyclohexyl)amino]carbonyl]amino]sulfonyl]phenyl]ethyl]-2-oxo-1H-pyrrole-1- carboxamide', "N'-{[4-(2-{[(3-ethyl-4-methyl-2-oxo-2,5-dihydro-1H-pyrrol-1-yl)carbonyl]amino}ethyl)phenyl]sulfonyl}-N-(4-methylcyclohexyl)carbamimidic acid", "N-[4-[2-(3-ethyl-4-methyl-2-oxo-3-pyrroline-1-carboxamido)-ethyl]-benzenesulfonyl]-N'-4-methylcyclohexylurea", 'trans-1-(4-(2-(3-ethyl-4-Me-2-oxo-2,5-dihydro-1H-pyrrole-1-carboxamido)ethyl)phenylsulfonyl)-3-(4-methylcyclohexyl)urea', 'trans-3-Ethyl-2,5-dihydro-4-methyl-N-[2-[4-[[[[(4-methyl cyclohexyl)amino]carbonyl]amino]sulfonyl]phenyl]ethyl]-2-oxo-1H-pyrrole-1-carboxamide', 'Trans-3-Ethyl-2,5-dihydro-4-methyl-N-[2-[4-[[[[(4-methylcyclohexyl)amino]carbonyl]amino]sulfonyl]phenyl]ethyl]-2-oxo-1H-pyrrole-1-carboxamide', 'trans-3-Ethyl-2,5-dihydro-4-methyl-N-[2-[4-[[[[trans-4-methylcyclohexyl)amino]carbonyl]amino]sulfonyl]phenyl]ethyl]-2-oxo-1H-pyrrole -1-carboxyamide', 'trans-3-Ethyl-2,5-dihydro-4-methyl-N-[2-[4-[[[[trans-4-methylcyclohexyl)amino]carbonyl]amino]sulfonyl]phenyl]ethyl]-2-oxo-1H-pyrrole-1-carboxyamide'] |
From Pubchem